Therapy News and Research

RSS

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

8 Dec 2017

Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age

Ann & Robert H. Lurie Children's Hospital of Chicago is one of the study sites in the open label Phase 3 study that showed safety and effectiveness of the cystic fibrosis drug Kalydeco (ivacaftor) in children ages 1 to 2 years.

8 Dec 2017

University of Adelaide receives $23.2 million for preterm birth research

The University of Adelaide has been awarded $23.2 million for new research tackling some of the world's most significant health problems, including one of the biggest killers of children: preterm birth.

8 Dec 2017

Brief test can help determine whether drugs, talk therapy work better for treating anxiety

Clinicians and patients often struggle to find the right treatment for anxiety, sometimes cycling through various therapies for months before the patient begins to feel their symptoms improve.

8 Dec 2017

IUPUI researchers receive $1.8 million grant to develop potential treatments for hydrocephalus

No drug treatment exists for hydrocephalus, the buildup of fluid known as "water on the brain" that can occur at any age.

8 Dec 2017

Gene therapy shows promising effect against blood clots, study states

A new study conducted in the Children's Hospital Of Philadelphia (CHOP) reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B.

8 Dec 2017

Bacteria may be involved in progression of cancers in the mouth, study suggests

Scientists at the School of Dental Science in Trinity have made an important discovery involving bacteria and a pre-cancerous growth called oral leukoplakia which can precede oral cancer.

7 Dec 2017

New first line combination therapy shows promising results in patients with advanced NSCLC

A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.

7 Dec 2017

Researchers test orange light treatment at emergency psychiatric care

Can orange light therapy help people who have serious mental disorders? Who hear voices and see things that aren't there? Or who are thinking about committing suicide?

7 Dec 2017

UA researcher awarded $2.3 million NIH grant to develop new treatments for depression

A University of Arizona College of Medicine-Phoenix researcher has received a $2.3 million grant from the National Institutes of Health to develop new treatments for depression.

7 Dec 2017

Clinical study uses genetic testing to match AML patients with new therapies

A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

6 Dec 2017

Physical activity in middle age linked to lower incidence of joint symptoms

In an Arthritis Care & Research analysis of 6661 participants in the Australian Longitudinal Study on Women's Health, maintaining at least low levels of physical activity throughout middle age was associated with lower prevalence and incidence of joint symptoms later in life.

6 Dec 2017

Hot flashes may increase risk of developing diabetes, study suggests

Hot flashes, undoubtedly the most common symptom of menopause, are not just uncomfortable and inconvenient, but numerous studies demonstrate they may increase the risk of serious health problems, including heart disease.

6 Dec 2017

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Multiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1.

6 Dec 2017

Newborn screening for SMA favored by most people, study finds

Research from the University of Warwick indicates that most people are in favor of newborn screening for the potentially deadly condition spinal muscular atrophy (SMA).

6 Dec 2017

Hyperbaric oxygen therapy can improve pathology of Alzheimer's disease, study shows

A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.

6 Dec 2017

Scientists develop multi-step method to harvest amniotic fluid

Amniotic fluid, the protective liquid surrounding an unborn baby, is discarded as medical waste during cesarean section deliveries.

6 Dec 2017

Intensive weight management program can help people with type 2 diabetes achieve remission

Type 2 diabetes can be reversed following an intensive weight management program, according a randomized trial in adults who have had the condition for up to 6 years, published in The Lancet.

6 Dec 2017

Binge eating can act as barrier to achieving weight-loss success

Someone who binge eats consumes an objectively large amount of food while feeling a loss of control over eating. When episodes occur weekly for several months, the action moves into the realm of binge-eating disorder.

5 Dec 2017

Immune-boosting drug combination may hold promise for treating ovarian cancer

Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone.

5 Dec 2017

Therapy News and Research

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations

Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age

University of Adelaide receives $23.2 million for preterm birth research

Brief test can help determine whether drugs, talk therapy work better for treating anxiety

IUPUI researchers receive $1.8 million grant to develop potential treatments for hydrocephalus

Gene therapy shows promising effect against blood clots, study states

Bacteria may be involved in progression of cancers in the mouth, study suggests

New first line combination therapy shows promising results in patients with advanced NSCLC

Researchers test orange light treatment at emergency psychiatric care

UA researcher awarded $2.3 million NIH grant to develop new treatments for depression

Clinical study uses genetic testing to match AML patients with new therapies

Physical activity in middle age linked to lower incidence of joint symptoms

Hot flashes may increase risk of developing diabetes, study suggests

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Newborn screening for SMA favored by most people, study finds

Hyperbaric oxygen therapy can improve pathology of Alzheimer's disease, study shows

Scientists develop multi-step method to harvest amniotic fluid

Intensive weight management program can help people with type 2 diabetes achieve remission

Binge eating can act as barrier to achieving weight-loss success

Immune-boosting drug combination may hold promise for treating ovarian cancer

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News